Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer

16 Dec 2020

Abstract excerpt

The therapeutic strategies of stage II/III colorectal cancer (CRC) patients after curative surgery remain controversial. In the clinical decision-making process, oncologists need to answer questions such as whether adjuvant chemotherapy is necessary or which therapeutic regimen should be given to each patient. At present, whether adjuvant chemotherapy should be applied is primarily based on histopathological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33333293
DOI: 10.1016/j.ymthe.2020.12.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal CancerPMID 33333293Read ↗

Current and future biomarkers in the treatment of colorectal cancerSemantic proximity Read ↗

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.Semantic proximity Read ↗

Pathogenesis and biomarkers of colorectal cancer by epigenetic alterationSemantic proximity Read ↗

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective.Semantic proximity Read ↗

Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and ChallengesSemantic proximity Read ↗

Molecular Network of Colorectal Cancer and Current Therapeutic OptionsSemantic proximity Read ↗

Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated reviewSemantic proximity Read ↗

Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updatesSemantic proximity Read ↗

New trends in molecular and cellular biomarker discovery for colorectal cancer.Semantic proximity Read ↗

Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategiesSemantic proximity Read ↗

Genetic and epigenetic alterations of colorectal cancerSemantic proximity Read ↗

Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.